JP2019163253A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019163253A5 JP2019163253A5 JP2019052389A JP2019052389A JP2019163253A5 JP 2019163253 A5 JP2019163253 A5 JP 2019163253A5 JP 2019052389 A JP2019052389 A JP 2019052389A JP 2019052389 A JP2019052389 A JP 2019052389A JP 2019163253 A5 JP2019163253 A5 JP 2019163253A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- polypeptide
- seq
- subsequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 46
- 229920001184 polypeptide Polymers 0.000 claims 33
- 108090000765 processed proteins & peptides Proteins 0.000 claims 33
- 102000004196 processed proteins & peptides Human genes 0.000 claims 33
- 101710105759 Major outer membrane porin Proteins 0.000 claims 12
- 101710164702 Major outer membrane protein Proteins 0.000 claims 12
- 125000000539 amino acid group Chemical group 0.000 claims 8
- 241001495184 Chlamydia sp. Species 0.000 claims 7
- 239000012634 fragment Substances 0.000 claims 7
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 101710116435 Outer membrane protein Proteins 0.000 claims 4
- 210000004899 c-terminal region Anatomy 0.000 claims 4
- 241000606153 Chlamydia trachomatis Species 0.000 claims 2
- 210000001744 T-lymphocyte Anatomy 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 2
- 102000036639 antigens Human genes 0.000 claims 2
- 108091007433 antigens Proteins 0.000 claims 2
- 229940038705 chlamydia trachomatis Drugs 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 241001647372 Chlamydia pneumoniae Species 0.000 claims 1
- 206010035664 Pneumonia Diseases 0.000 claims 1
- 108010076504 Protein Sorting Signals Proteins 0.000 claims 1
- 229940037003 alum Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000003623 enhancer Substances 0.000 claims 1
- 108020001507 fusion proteins Proteins 0.000 claims 1
- 102000037865 fusion proteins Human genes 0.000 claims 1
- 230000002163 immunogen Effects 0.000 claims 1
- 230000005847 immunogenicity Effects 0.000 claims 1
- 239000002955 immunomodulating agent Substances 0.000 claims 1
- 230000002584 immunomodulator Effects 0.000 claims 1
- 229940121354 immunomodulator Drugs 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021148819A JP7506930B2 (ja) | 2013-03-18 | 2021-09-13 | クラミジア種（Ｃｈｌａｍｙｄｉａ ｓｐ．）に対するワクチン |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201300155 | 2013-03-18 | ||
| DKPA201300155 | 2013-03-18 | ||
| DKPA201300684 | 2013-12-11 | ||
| DKPA201300684 | 2013-12-11 | ||
| JP2016503549A JP2016514713A (ja) | 2013-03-18 | 2014-03-17 | クラミジア種（Ｃｈｌａｍｙｄｉａｓｐ．）に対するワクチン |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016503549A Division JP2016514713A (ja) | 2013-03-18 | 2014-03-17 | クラミジア種（Ｃｈｌａｍｙｄｉａｓｐ．）に対するワクチン |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021148819A Division JP7506930B2 (ja) | 2013-03-18 | 2021-09-13 | クラミジア種（Ｃｈｌａｍｙｄｉａ ｓｐ．）に対するワクチン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019163253A JP2019163253A (ja) | 2019-09-26 |
| JP2019163253A5 true JP2019163253A5 (OSRAM) | 2020-01-16 |
| JP7510142B2 JP7510142B2 (ja) | 2024-07-03 |
Family
ID=50639248
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016503549A Pending JP2016514713A (ja) | 2013-03-18 | 2014-03-17 | クラミジア種（Ｃｈｌａｍｙｄｉａｓｐ．）に対するワクチン |
| JP2019052389A Active JP7510142B2 (ja) | 2013-03-18 | 2019-03-20 | クラミジア種（Ｃｈｌａｍｙｄｉａ ｓｐ．）に対するワクチン |
| JP2021148819A Active JP7506930B2 (ja) | 2013-03-18 | 2021-09-13 | クラミジア種（Ｃｈｌａｍｙｄｉａ ｓｐ．）に対するワクチン |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016503549A Pending JP2016514713A (ja) | 2013-03-18 | 2014-03-17 | クラミジア種（Ｃｈｌａｍｙｄｉａｓｐ．）に対するワクチン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021148819A Active JP7506930B2 (ja) | 2013-03-18 | 2021-09-13 | クラミジア種（Ｃｈｌａｍｙｄｉａ ｓｐ．）に対するワクチン |
Country Status (20)
| Country | Link |
|---|---|
| US (4) | US20140275478A1 (OSRAM) |
| EP (1) | EP2976355B1 (OSRAM) |
| JP (3) | JP2016514713A (OSRAM) |
| CN (2) | CN113185587A (OSRAM) |
| AU (1) | AU2014234765B2 (OSRAM) |
| BR (1) | BR112015023886B1 (OSRAM) |
| CA (1) | CA2907199C (OSRAM) |
| CY (1) | CY1122905T1 (OSRAM) |
| DK (1) | DK2976355T3 (OSRAM) |
| ES (1) | ES2781579T3 (OSRAM) |
| HR (1) | HRP20200511T1 (OSRAM) |
| HU (1) | HUE048573T2 (OSRAM) |
| LT (1) | LT2976355T (OSRAM) |
| PL (1) | PL2976355T3 (OSRAM) |
| PT (1) | PT2976355T (OSRAM) |
| RS (1) | RS60135B1 (OSRAM) |
| RU (1) | RU2723046C2 (OSRAM) |
| SI (1) | SI2976355T1 (OSRAM) |
| SM (1) | SMT202000160T1 (OSRAM) |
| WO (1) | WO2014146663A1 (OSRAM) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3256219B1 (en) | 2015-02-10 | 2021-11-17 | Ohio State Innovation Foundation | Chlamydia-activated b cell platforms and methods thereof |
| CN104800841B (zh) * | 2015-03-02 | 2019-04-02 | 中国农业科学院兰州兽医研究所 | 牦牛流产衣原体灭活疫苗及其制备方法 |
| KR20170134978A (ko) | 2015-03-24 | 2017-12-07 | 유니버시테이트 젠트 | 클라미디아 수이스의 검출을 위한 방법 및 펩타이드 |
| WO2017075653A1 (en) * | 2015-11-04 | 2017-05-11 | University Of The Sunshine Coast | Chlamydia antigens and uses thereof |
| US10835601B2 (en) | 2015-11-10 | 2020-11-17 | Ohio State Innovation Foundation | Methods and compositions related to accelerated humoral affinity |
| NL2019320B1 (en) * | 2017-03-02 | 2018-09-21 | Biosparq B V | Diagnostic method and system for diagnosis |
| AU2018237338A1 (en) * | 2017-03-23 | 2019-10-10 | Ohio State Innovation Foundation | Recombinant |
| RU2721123C1 (ru) * | 2019-09-26 | 2020-05-18 | федеральное государственное бюджетное учреждение «Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи» Министерства здравоохранения Российской Федерации | Штамм рекомбинантной псевдоаденовирусной частицы, экспрессирующий химерный ген MBL-CT666 Chlamydia trachomatis, способ его получения, иммуногенная композиция для защиты от урогенитального хламидиоза человека |
| EP4267176A1 (en) * | 2020-12-23 | 2023-11-01 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Chlamydia vaccine based on targeting momp vs4 antigen to antigen presenting cells |
| CN116854812B (zh) * | 2022-03-23 | 2024-09-24 | 东莞市朋志生物科技有限公司 | 抗沙眼衣原体的抗体、检测沙眼衣原体的试剂和试剂盒 |
| CN115975049A (zh) * | 2022-11-12 | 2023-04-18 | 北京成大天和生物科技有限公司 | 一种沙眼衣原体重组蛋白及其制备方法和应用 |
| US12263213B2 (en) * | 2023-03-02 | 2025-04-01 | Sanofi Pasteur | Compositions for use in treatment of Chlamydia |
| WO2025104023A1 (en) | 2023-11-13 | 2025-05-22 | Ziphius Nv | MODIFIED ALPHAVIRAL nsP3 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4599230A (en) | 1984-03-09 | 1986-07-08 | Scripps Clinic And Research Foundation | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
| US4599231A (en) | 1984-03-09 | 1986-07-08 | Scripps Clinic And Research Foundation | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
| US4608251A (en) | 1984-11-09 | 1986-08-26 | Pitman-Moore, Inc. | LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues |
| US4601903A (en) | 1985-05-01 | 1986-07-22 | The United States Of America As Represented By The Department Of Health And Human Services | Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease |
| US5869608A (en) * | 1989-03-17 | 1999-02-09 | The United States Of America As Represented By The Department Of Health And Human Services | Nucleotide and amino acid sequences of the four variable domains of the major outer membrane proteins of Chlamydia trachomatis |
| US5837268A (en) * | 1991-10-16 | 1998-11-17 | University Of Saskatchewan | GnRH-leukotoxin chimeras |
| GB9215780D0 (en) * | 1992-07-24 | 1992-09-09 | Univ London Pharmacy | Peptide compounds |
| DK0652962T3 (da) * | 1992-07-31 | 1999-08-23 | Medeva Holdings Bv | Ekspression af rekombinante fusionsproteiner i attenuerede bakterier |
| WO1994006827A1 (en) | 1992-09-18 | 1994-03-31 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Synthetic peptide vaccine for chlamydia trachomatis |
| GB9516293D0 (en) * | 1995-08-09 | 1995-10-11 | Immunova Ltee | Novel peptides and their use as vaccines |
| JP2002512622A (ja) * | 1997-05-06 | 2002-04-23 | バンダービルト ユニバーシティー | クラミジアにより引き起こされる感染の診断および管理のための抗クラミジア剤の組成物 |
| US7651857B2 (en) * | 2000-12-22 | 2010-01-26 | The Mathilda And Terence Kennedy Institute Of Rheumatology Trust | Methods for enhancing antigen presentation |
| US7105171B2 (en) | 2002-03-07 | 2006-09-12 | The Regents Of The University Of California | Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia |
| CN1812809A (zh) * | 2003-06-26 | 2006-08-02 | 希龙公司 | 用于沙眼衣原体的免疫原性组合物 |
| PT1812058E (pt) * | 2004-10-25 | 2012-09-17 | Statens Seruminstitut | Antigénios de chlamydia trachomatis para vacina e utilização em diagnóstico |
| US7964200B2 (en) * | 2005-05-18 | 2011-06-21 | Children's Hospital & Research Center At Oakland | Methods and compositions for immunizing against Chlamydia infection |
| TW201012929A (en) * | 2008-09-29 | 2010-04-01 | Univ Nat Pingtung Sci & Tech | A hybridoma cell line producing monoclonal antibodies against chalmydophila aborts |
| CA2787697C (en) * | 2009-01-29 | 2018-03-20 | British Columbia Cancer Agency Branch | Compositions comprising chlamydia antigens |
| US8735543B2 (en) * | 2010-05-28 | 2014-05-27 | Spixia Biotechnology Ab | Chimeric MOMP antigen |
| US9308248B2 (en) | 2011-06-17 | 2016-04-12 | Universiteit Gent | Vaccines for Chlamydia |
-
2014
- 2014-03-17 JP JP2016503549A patent/JP2016514713A/ja active Pending
- 2014-03-17 HU HUE14721199A patent/HUE048573T2/hu unknown
- 2014-03-17 ES ES14721199T patent/ES2781579T3/es active Active
- 2014-03-17 RU RU2015141214A patent/RU2723046C2/ru active
- 2014-03-17 LT LTEP14721199.9T patent/LT2976355T/lt unknown
- 2014-03-17 SI SI201431541T patent/SI2976355T1/sl unknown
- 2014-03-17 SM SM20200160T patent/SMT202000160T1/it unknown
- 2014-03-17 RS RS20200360A patent/RS60135B1/sr unknown
- 2014-03-17 DK DK14721199.9T patent/DK2976355T3/da active
- 2014-03-17 CA CA2907199A patent/CA2907199C/en active Active
- 2014-03-17 CN CN202110407442.8A patent/CN113185587A/zh active Pending
- 2014-03-17 US US14/216,403 patent/US20140275478A1/en not_active Abandoned
- 2014-03-17 EP EP14721199.9A patent/EP2976355B1/en active Active
- 2014-03-17 AU AU2014234765A patent/AU2014234765B2/en active Active
- 2014-03-17 HR HRP20200511TT patent/HRP20200511T1/hr unknown
- 2014-03-17 PL PL14721199T patent/PL2976355T3/pl unknown
- 2014-03-17 CN CN201480026477.5A patent/CN105377879B/zh active Active
- 2014-03-17 WO PCT/DK2014/000015 patent/WO2014146663A1/en not_active Ceased
- 2014-03-17 BR BR112015023886-6A patent/BR112015023886B1/pt active IP Right Grant
- 2014-03-17 PT PT147211999T patent/PT2976355T/pt unknown
-
2018
- 2018-04-18 US US15/956,731 patent/US10925954B2/en active Active - Reinstated
-
2019
- 2019-03-20 JP JP2019052389A patent/JP7510142B2/ja active Active
-
2020
- 2020-03-27 CY CY20201100285T patent/CY1122905T1/el unknown
-
2021
- 2021-01-22 US US17/155,264 patent/US20210205433A1/en active Pending
- 2021-09-13 JP JP2021148819A patent/JP7506930B2/ja active Active
-
2025
- 2025-05-02 US US19/197,254 patent/US20250255951A1/en active Pending